MDS International Foundation

May 31, 2019

The Aplastic Anemia and MDS International Foundation records educational webinars for patients.

July 25, 2018

Dr. Inga Hofman Zhang from the University of Wisconsin School of Medicine provides an update on treating MDS in children.

July 25, 2018

Dr. Naval Daver from MD Anderson Cancer Center talks about the relationship between MDS and AML and discusses new and novel treatments for both diseases.

July 25, 2018

Dr. Antonio Risitano, a hematologist from the Univeristy of Naples, discusses the most current thinking on PNH and its treatment. Questions answered include:

July 25, 2018

Dr. Eric Padrone, a hematologist from H. Lee Moffit Cancer Center, discusses current thinking on MDS/MPN overlap disorders and myelofibrosis.

July 24, 2018

Dr. Timothy Olson, a pediatric hematologist at Children's Hospital of Philadelphia, discusses the most current thinking on treatment of children with aplastic anemia. This video was recorded at the Aplastic Anemia and MDS International Foundation's Scientific Symposium in March, 2018.

July 24, 2018

Dr. Lucy Godley, University of Chicago, and Dr. Luca Malcovati, University of Pavia, discuss the highlights of their session on Genetics and Genomics of Bone Marrow Failure at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.

July 24, 2018

Dr. David Margolis, Medical College of Wisconsin, and Dr. Danielle Townsley, MedImmune, discuss the highlights of their session on Treatment Options for Aplastic Anemia at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018. Topics include precision medicine, eltrombopag, and bone marrow transplantation.

July 24, 2018

Dr. Antonio Risitano, University of Naples and Dr. Regis Peffault DeLatour, Hospital de St. Louis, discuss recent research on treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.

July 24, 2018

Dr. Timothy Graubert, Massachusetts General Hospital and Dr. Stephanie Halene, Yale University School of Medicine discuss the highlights of their session on the Biology of Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.